文献速递免疫规划传染病防控与疫情报告

实验室评估口蹄疫疫苗保护力的方法综述

Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory.
PubMed 文献 · Vaccine · 2019-08-09

该综述讨论了口蹄疫疫苗质量控制中的血清学技术,包括效力检测、疫苗匹配和接种后监测,并比较了抗原定量与核苷酸测序等替代方法。作者指出血清学预测保护力有实用价值但存在局限,建议采用整体性方法并结合多种数据来源审慎解读结果。

要点

  • 血清学是预测口蹄疫疫苗保护力的常用手段,但受动物应答差异和检测方法影响。
  • 抗体与病毒相互作用因血清型和毒株而异,保护力还受接种方案和攻毒条件影响。
  • 建议综合现场、实验和实验室数据整体评估,并谨慎解读血清学结果。

核心结论

  • 血清学可用于预测口蹄疫疫苗保护力,但简单统一的判定标准可能导致错误预测,推荐采用整体性方法评估。

研究设计与样本

  • 综述涵盖口蹄疫疫苗质量控制中的血清学技术,包括效力检测、疫苗匹配和接种后监测,并讨论抗原定量和核苷酸测序等替代实验室程序。

主要发现

  • 动物对疫苗的应答和保护机制存在差异,抗体特性多样且检测方法测量内容不同。
  • 抗体与病毒相互作用可能因血清型和毒株而异,保护力受接种方案及现场病毒攻击性质和时机影响。
  • 使用生物试剂的检测难以标准化,且用于检测校准和验证的交叉保护数据稀缺。

关键数值与推荐

  • 新的抗体亲和力和同种型检测似乎是评估交叉保护性接种后血清学应答的有前景替代方法,可兼顾疫苗效力和匹配性。

临床怎么用

  • 选择适当的血清学检测或检测组合及临界值后,应结合背景谨慎解读结果。
  • 需开展更多现场研究以量化交叉保护及其与体外检测指标的相关性。

局限性

  • 交叉保护实验攻击研究机会有限,且方法不能完全反映现实情况。
  • 血清学预测保护力存在局限,简单化检测程序及解读可能导致预测不佳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Foot-and-mouth disease (FMD) vaccines must be carefully selected and their application closely monitored to optimise their effectiveness. This review covers serological techniques for FMD vaccine quality control, including potency testing, vaccine matching and post-vaccination monitoring. It also discusses alternative laboratory procedures, such as antigen quantification and nucleotide sequencing, and briefly compares the approaches for FMD with those for measuring protection against influenza virus, where humoral immunity is also important. Serology is widely used to predict the protection afforded by vaccines and has great practical utility but also limitations. Animals differ in their responses to vaccines and in the protective mechanisms that they develop. Antibodies have a variety of properties and tests differ in what they measure. Antibody-virus interactions may vary between virus serotypes and strains and protection may be affected by the vaccination regime and the nature and timing of field virus challenge. Finally, tests employing biological reagents are difficult to standardise, whilst cross-protection data needed for test calibration and validation are scarce. All of this is difficult to reconcile with the desire for simple and universal criteria and thresholds for evaluating vaccines and vaccination responses and means that oversimplification of test procedures and their interpretation can lead to poor predictions. A holistic approach is therefore recommended, considering multiple sources of field, experimental and laboratory data. New antibody avidity and isotype tests seem promising alternatives to evaluate cross-protective, post-vaccination serological responses, taking account of vaccine potency as well as match. After choosing appropriate serological tests or test combinations and cut-offs, results should be interpreted cautiously and in context. Since opportunities for experimental challenge studies of cross-protection are limited and the approaches incompletely reflect real life, more field studies are needed to quantify cross-protection and its correlation to in vitro measurements.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Paton DJ, Reeve R, Capozzo AV, et al. Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory. Vaccine. 2019. PMID: 31405637. doi:10.1016/j.vaccine.2019.07.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。